YOUR DOSE OF MEDICINE
EULAR recommendations on steroids: ‘As necessary but as little as possible’
by Charles C. Chante MD - October 20, 2019 - 12:00am
Glucocorticosteroids remain an important therapeutic option for many patients with rheumatic and nonrheumatic disease, but careful assessment of their relative benefits and risks needs to be considered when prescribing,...
How to prioritize CV risk reduction in type 2 diabetes
by Charles C. Chante MD - October 13, 2019 - 12:00am
The pooled analysis showed that initiation of SGLT2 inhibitors was associated with a significantly lower risk of heart failure events, compared with other glucose-lowering drugs (risk ration, 0.61; P less than .001.)....
How to prioritize CV risk reduction in type 2 diabetes
by Charles C. Chante MD - October 6, 2019 - 12:00am
In the opinion of a doctor, the paradigm of treating patients with type 2 diabetes should shift from a narrow focus on hemoglobin A control to a broader strategy of reducing cardiovascular risk.
Failure to prevent most heart failure could be avoided
by Charles C. Chante MD - September 29, 2019 - 12:00am
Until the randomized EMPA-REG-OUTCOME trial of the sodium-glucose transporter 2 (SGLT-2) inhibitors empagliflozin (Jardiance), no glucose-lowering drug available for treatment of type 2 diabetes had shown any benefit...
Failure to prevent most heart failure could be avoided
by Charles C. Chante MD - September 22, 2019 - 12:00am
More than 960,000 new cases of heart failure will occur in the United States this year – and most of them could have been prevented, asserted at Annual Cardiovascular Conference.
Long-term effects of using ketamine for depression are uncertain
by Charles C. Chante MD - September 15, 2019 - 12:00am
Low doses of ketamine, an N- methyl- D- aspirate glutamate receptor antagonist, can produce benefits that are unprecedented in the history of treating major depression.
Ledipasvir/Sofosbuvir looks good in HBV-coinfected patients
by Charles C. Chante MD - September 8, 2019 - 12:00am
For patients with chronic hepatitis C and hepatitis B virus co-infection, 12 weeks of ledipasvir/sofosbuvir therapy achieved a 100 percent sustained viral response rate without causing liver failure or death in a...
Case for rivaroxaban and aspirin for pad gets stronger
by Charles C. Chante MD - September 1, 2019 - 12:00am
Combination treatment with aspirin and low dosage of the anticoagulant rivaroxaban has a broader benefit for reducing adverse events in patients with peripheral artery disease than initially reported from the COMPASS...
No short-term link found between PPIs, heart attack
by Charles C. Chante MD - August 25, 2019 - 12:00am
Proton pump inhibitor conferred no short-term increase in risk for myocardial infarction in a large retrospective insurance claims study.
Diabetes – high rate of med discontinuation requires vigilance
by Charles C. Chante MD - August 18, 2019 - 12:00am
Most patients with type 2 diabetes mellitus stop taking their medication within a year, and nearly one-third stop within the first 3 months, a retrospective analysis of claims data for more than 324,000 patients...
ACIP unanimously recommends new hepatitis B vaccine
by Charles C. Chante MD - August 11, 2019 - 12:00am
At a meeting of the Center for Disease Control and Prevention’s advisory committee on immunization practices, members unanimously voted to include HEPLISAV-B on the ACIP list of recommended products to vaccinate...
Aspirin may protect against dementia in type 2 diabetes
by Charles C. Chante MD - August 4, 2019 - 12:00am
Daily low-dose aspirin reduce the incidence of dementia by more than one-third in patients with type 2 diabetes mellitus in the randomized JPAD 2 study.
Head injury linked to amyloid deposition decades later
by Charles C. Chante MD - July 28, 2019 - 12:00am
A history of head injury is associated with increased amyloid deposition in the brain, both globally and in the frontal cortex, according to PET imaging in 329 older adults without dementia.
Blood test approved for patients with concussions
by Charles C. Chante MD - July 21, 2019 - 12:00am
The Food and Drug Administration approved a new blood test on Feb. 14 – the Banyan Brain Trauma Indicator – for assessing patients with mild traumatic brain injuries, also known as concussions.
Gluten-free diet tied to heavy metal bioaccumulation
by Charles C. Chante MD - July 14, 2019 - 12:00am
A gluten-free diet was associated with significantly increased blood levels of mercury, lead, and cadmium and with significantly increased urinary levels of arsenic in a large cross-sectional; population-based survey...
COPD’s month of danger
by Charles C. Chante MD - July 7, 2019 - 12:00am
New use of inhaled long-acting beta, agonists or long-acting antimuscarinic antagonists was associated with a 1.5-fold increased cardiovascular risk within 30 days of initiation in patients with chronic obstructive...
Beware the COPD exacerbation
by Charles C. Chante MD - June 30, 2019 - 12:00am
A 70-year-old man with chronic obstructive pulmonary disease (COPD) is admitted with increased shortness of breath.
Online education linked to less anxiety in colonoscopy
by Charles C. Chante MD - June 23, 2019 - 12:00am
An online education program appeared to dampen anxiety levels in colonoscopy patients and even seemed to reduce the burden of the procedure in terms of time and medication used, a study showed.
NASH rapidly overtaking hepatitis C as cause of liver cancer
by Charles C. Chante MD - June 16, 2019 - 12:00am
Nonalcoholic steatohepatitis (NASH) is rapidly eclipsing hepatitis C virus (HCV) infection as the leading contributor to liver cancer in the United States.
Opioids linked to mortality in inflammatory bowel disease
by Charles C. Chante MD - June 9, 2019 - 12:00am
Among patients with inflammatory bowel disease, opioid prescriptions tripled during a recent 20-year period, and heavy use of strong opioids was significant predictor of all cause mortality, according to large cohort...
1 | 2 | 3 | 4 | 5 | ... | 37 | 38 | 39 | 40 | 41
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

SIGN IN
or sign in with